Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating costs and expenses
General and administrative	$ 7,734	$ 4,057
Research and development	559	1,020
Research and development - license acquired	1,148	1,469
Total operating expenses	9,441	6,546
Loss from operations	(9,441)	(6,546)
Other income (expenses)
Other income	135	19
Interest income	252
(Loss) gains on marketable securities	(1,743)	1,001
Change in fair value of investment	3,626	(6,811)
Total other income (expenses)	2,270	(5,791)
Net loss	$ (7,171)	$ (12,337)
Net loss per share, basic and diluted
Basic and Diluted (in Dollars per share)	$ (0.09)	$ (0.44)
Weighted average number of shares outstanding, basic and diluted
Basic and Diluted (in Shares)	82,398,369	28,074,116